Bax/Bcl-2 Cascade Is Regulated by the EGFR Pathway: Therapeutic Targeting of Non-Small Cell Lung Cancer

Bax/Bcl-2 Cascade Is Regulated by the EGFR Pathway: Therapeutic Targeting of Non-Small Cell Lung Cancer

Show other versions (1)

Non-small cell lung carcinoma (NSCLC) comprises 80%–85% of lung cancer cases. EGFR is involved in several cancer developments, including NSCLC. The EGFR pathway regulates the Bax/Bcl-2 cascade in NSCLC. Increasing understanding of the molecular mechanisms of fundamental tumor progression has guided...

Full description

Bibliographic Details
Main Authors: Manzar Alam, Shoaib Alam, Anas Shamsi, Mohd Adnan, Abdelbaset Mohamed Elasbali, Waleed Abu Al-Soud, Mousa Alreshidi, Yousef MohammedRabaa Hawsawi, Anitha Tippana, Pasupuleti Visweswara Rao, Md. Imtaiyaz Hassan
Format: Article
Language:English
English
Published: Frontiers Media SA 2022
Subjects:
RC254-282 Neoplasms. Tumors. Oncology Including cancer and carcinogens
Online Access:https://eprints.ums.edu.my/id/eprint/33339/1/Bax.pdf
https://eprints.ums.edu.my/id/eprint/33339/2/Bax1.pdf

Internet

https://eprints.ums.edu.my/id/eprint/33339/1/Bax.pdf
https://eprints.ums.edu.my/id/eprint/33339/2/Bax1.pdf

Similar Items